Phase 3 Double-blind Multicenter Randomized Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Biktarvy® (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Virologically Suppressed People With HIV-1

Project: Research

Project Details

StatusActive
Effective start/end date14/05/24 → 13/05/26

Keywords

  • Clinical Trials
  • GS-US-621-6290